Evidence map›Paper›PMID 32038712›Full record

ArticleFrontiers in genetics2019

Non-Negative Symmetric Low-Rank Representation Graph Regularized Method for Cancer Clustering Based on Score Function.

Conghai Lu, Juan Wang, Jinxing Liu, Chunhou Zheng, Xiangzhen Kong, Xiaofeng Zhang

Abstract read
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Conghai LuSchool of Information Science and Engineering, Qufu Normal University, Rizhao, China.
Juan WangSchool of Information Science and Engineering, Qufu Normal University, Rizhao, China.
Jinxing LiuSchool of Information Science and Engineering, Qufu Normal University, Rizhao, China.
Chunhou ZhengCollege of Electrical Engineering and Automation, Anhui University, Hefei, China.
Xiangzhen KongSchool of Information Science and Engineering, Qufu Normal University, Rizhao, China.
Xiaofeng ZhangSchool of Information and Electrical Engineering, Ludong University, Yantai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As an important approach to cancer classification, cancer sample clustering is of particular importance for cancer research. For high dimensional gene expression data, examining approaches to selecting characteristic genes with high identification for cancer sample clustering is an important research area in the bioinformatics field. In this paper, we propose a novel integrated framework for cancer clustering known as the non-negative symmetric low-rank representation with graph regularization based on score function (NSLRG-S). First, a lowest rank matrix is obtained after NSLRG decomposition. The lowest rank matrix preserves the local data manifold information and the global data structure information of the gene expression data. Second, we construct the Score function based on the lowest rank matrix to weight all of the features of the gene expression data and calculate the score of each feature. Third, we rank the features according to their scores and select the feature genes for cancer sample clustering. Finally, based on selected feature genes, we use the K-means method to cluster the cancer samples. The experiments are conducted on The Cancer Genome Atlas (TCGA) data. Comparative experiments demonstrate that the NSLRG-S framework can significantly improve the clustering performance.

Indexed as

cancer gene expression dataclusteringfeature selectionlow-rank representationscore function

Identifiers

PMID32038712
PMCPMC6987458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.